Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00427804 · ClinicalTrials.gov registry record · NA
Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption
A NA study, sponsored by Atlanta VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT00427804: Completed NA study, sponsored by Atlanta VA Medical Center.
NCT00427804 is a NA study that has completed, run by Atlanta VA Medical Center. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00427804, a NA study, has completed, sponsored by Atlanta VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This study is a pilot study to determine whether patients with TNFα excess have decreased calcium absorption in response to calcitriol (1,25-dihydroxyvitamin D, the active form of vitamin D) compared to normal controls. This initial pilot study is being done to determine if it is feasible to conduct a study where TNFα could be blocked (e.g., by anti-TNFα therapy such as Enbrel® or Remicade®) to improve vitamin D dependant calcium absorption and thus bone health.
Interventions
- DRUG calcitriol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT00427804 record still lists
NCT00427804 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which calcitriol is the first listed.
NCT00427804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00427804 about?
NCT00427804 is a clinical study titled "Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption". This study is a pilot study to determine whether patients with TNFα excess have decreased calcium absorption in response to calcitriol (1,25-dihydroxyvitamin D, the active form of vitamin D) compared to normal controls. This initial pilot study is being done to determine if it is feasible to conduct...
What is the current status of trial NCT00427804?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2007-01. Estimated completion is 2009-11.
What interventions are being tested in trial NCT00427804?
The interventions under investigation include: calcitriol (DRUG).
Who is sponsoring clinical trial NCT00427804?
This trial is sponsored by Atlanta VA Medical Center, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00427804's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia